Direct oral anticoagulants in sickle cell disease: a systematic review and meta-analysis
Blood Adv
.
2022 Sep 13;6(17):5061-5066.
doi: 10.1182/bloodadvances.2022007308.
Authors
Waail Rozi
1
,
Alaa Rahhal
2
,
Elrazi A Ali
1
,
Abdulrahman Al-Mashdali
1
,
Yousef Hilan
1
,
Ibrahim Khamees
1
,
Liam J Fernyhough
3
4
,
Mohamed A Yassin
3
4
Affiliations
1
Internal Medicine.
2
Pharmacy Department, and.
3
Department of Hematology, National Centre for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar; and.
4
Department of Medical Education, Weill Cornell Medicine, Doha, Qatar.
PMID:
35728061
PMCID:
PMC9631619
DOI:
10.1182/bloodadvances.2022007308
No abstract available
Publication types
Meta-Analysis
Systematic Review
MeSH terms
Anemia, Sickle Cell* / complications
Anemia, Sickle Cell* / drug therapy
Anticoagulants / therapeutic use
Atrial Fibrillation*
Humans
Substances
Anticoagulants